Jones and her coauthors concluded such a tool had the potential to improve evidence-based testing in pediatric diarrhea and ...

SAN FRANCISCO, CA / ACCESSWIRE / August 1, 2023 / Jaguar Health (NASDAQ:JAGX) ("the Company") today announced the activation by the U.S. Food and Drug Administration (FDA) of a physician-requested ...

Salix announced that the FDA has approved Fulyzaq (crofelemer) delayed-release tablets for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy ...

For those experiencing paradoxical diarrhea, the body sends confusing signals that can leave both patients and healthcare providers perplexed. This unusual digestive condition creates a seemingly ...

Persistent diarrhea is a commonly encountered but poorly recognized and often misunderstood illness, according to Herbert DuPont, MD, director of the Center for Infectious Diseases at The University ...

Colesevelam was superior to placebo in inducing remission in patients with bile acid diarrhea with no serious adverse events reported, according to results published in The Lancet Gastroenterology & ...

In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia ...

Potential treatment for patients with breast cancer with metastasis to the brain with crofelemer would augment the ...

Abbreviations: mITT, modified intent to treat; TTROD, time to resolution of diarrhea. *Comparing fidaxomicin and vancomycin. †Log-rank P = .0003, with versus without cancer. ‡Log-rank P = .145, with ...

Japan had 254.8 cases of ulcerative colitis and 77 cases of Crohn's per 100,000 people, and a new study shows that the cases ...

Coming to a monetary amount for what a life is “worth” is not an easy task, and sometimes does not seem to make sense. For example, the untimely death of a child, which seems most tragic, does not ...

Researchers from USC and Duke report in Science Advances that the persistent "know-do gap"—where clinicians know guidelines ...